JPH03505979A - 高分子表面の調製 - Google Patents
高分子表面の調製Info
- Publication number
- JPH03505979A JPH03505979A JP89501785A JP50178589A JPH03505979A JP H03505979 A JPH03505979 A JP H03505979A JP 89501785 A JP89501785 A JP 89501785A JP 50178589 A JP50178589 A JP 50178589A JP H03505979 A JPH03505979 A JP H03505979A
- Authority
- JP
- Japan
- Prior art keywords
- polymer
- latent reactive
- molecule
- reactive group
- substrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000642 polymer Polymers 0.000 title claims description 156
- 238000000034 method Methods 0.000 claims description 66
- 239000000758 substrate Substances 0.000 claims description 54
- 239000000203 mixture Substances 0.000 claims description 37
- 239000000178 monomer Substances 0.000 claims description 25
- -1 aryl azide Chemical group 0.000 claims description 21
- 229920001223 polyethylene glycol Polymers 0.000 claims description 19
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 17
- 229920002674 hyaluronan Polymers 0.000 claims description 17
- 229960003160 hyaluronic acid Drugs 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 16
- 239000002202 Polyethylene glycol Substances 0.000 claims description 12
- 239000008199 coating composition Substances 0.000 claims description 12
- 102000008186 Collagen Human genes 0.000 claims description 11
- 108010035532 Collagen Proteins 0.000 claims description 11
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 238000000576 coating method Methods 0.000 claims description 10
- 229920001436 collagen Polymers 0.000 claims description 10
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 9
- 230000002209 hydrophobic effect Effects 0.000 claims description 9
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 9
- 230000004913 activation Effects 0.000 claims description 8
- 239000011248 coating agent Substances 0.000 claims description 8
- 238000006116 polymerization reaction Methods 0.000 claims description 8
- 229920001661 Chitosan Polymers 0.000 claims description 6
- 150000003254 radicals Chemical class 0.000 claims description 6
- 230000004044 response Effects 0.000 claims description 6
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 5
- 229920000669 heparin Polymers 0.000 claims description 5
- 229960002897 heparin Drugs 0.000 claims description 5
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical group CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 claims description 4
- 150000002576 ketones Chemical class 0.000 claims description 4
- 230000000704 physical effect Effects 0.000 claims description 3
- 230000003213 activating effect Effects 0.000 claims description 2
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical group C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 claims description 2
- 239000012965 benzophenone Substances 0.000 claims description 2
- 229920006037 cross link polymer Polymers 0.000 claims description 2
- 239000003973 paint Substances 0.000 claims 2
- 240000005893 Pteridium aquilinum Species 0.000 claims 1
- 235000009936 Pteridium aquilinum Nutrition 0.000 claims 1
- 150000002500 ions Chemical class 0.000 claims 1
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 claims 1
- 230000003647 oxidation Effects 0.000 claims 1
- 238000007254 oxidation reaction Methods 0.000 claims 1
- 229920013730 reactive polymer Polymers 0.000 claims 1
- 230000000638 stimulation Effects 0.000 claims 1
- 239000010409 thin film Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 description 45
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 25
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 239000000047 product Substances 0.000 description 21
- 229910001868 water Inorganic materials 0.000 description 21
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 15
- 239000003153 chemical reaction reagent Substances 0.000 description 14
- 235000018102 proteins Nutrition 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 14
- 108090000623 proteins and genes Proteins 0.000 description 14
- 239000002904 solvent Substances 0.000 description 14
- 239000000463 material Substances 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 11
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- 239000004793 Polystyrene Substances 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 229920002223 polystyrene Polymers 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 229920002523 polyethylene Glycol 1000 Polymers 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 229910002651 NO3 Inorganic materials 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 238000000502 dialysis Methods 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 239000000607 artificial tear Substances 0.000 description 5
- 125000000524 functional group Chemical group 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 102000004266 Collagen Type IV Human genes 0.000 description 3
- 108010042086 Collagen Type IV Proteins 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 235000019687 Lamb Nutrition 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000012644 addition polymerization Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 229940014041 hyaluronate Drugs 0.000 description 3
- 238000006303 photolysis reaction Methods 0.000 description 3
- 230000015843 photosynthesis, light reaction Effects 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- ZSLUVFAKFWKJRC-IGMARMGPSA-N 232Th Chemical compound [232Th] ZSLUVFAKFWKJRC-IGMARMGPSA-N 0.000 description 2
- IFQUPKAISSPFTE-UHFFFAOYSA-N 4-benzoylbenzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(=O)C1=CC=CC=C1 IFQUPKAISSPFTE-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 2
- 102000016359 Fibronectins Human genes 0.000 description 2
- 108010067306 Fibronectins Proteins 0.000 description 2
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- 229920002534 Polyethylene Glycol 1450 Polymers 0.000 description 2
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229910052776 Thorium Inorganic materials 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 2
- 229910001626 barium chloride Inorganic materials 0.000 description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 208000035196 congenital hypomyelinating 2 neuropathy Diseases 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 210000000399 corneal endothelial cell Anatomy 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- ZQMIGQNCOMNODD-UHFFFAOYSA-N diacetyl peroxide Chemical compound CC(=O)OOC(C)=O ZQMIGQNCOMNODD-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000005281 excited state Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 108010074605 gamma-Globulins Proteins 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000005661 hydrophobic surface Effects 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920000768 polyamine Polymers 0.000 description 2
- 229920006254 polymer film Polymers 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- SETGHOXIRKRIDF-IBGZPJMESA-N prop-2-enoyl (2S)-6-amino-2-[(4-benzoylbenzoyl)amino]hexanoate Chemical group C(C1=CC=CC=C1)(=O)C1=CC=C(C(=O)N[C@@H](CCCCN)C(=O)OC(C=C)=O)C=C1 SETGHOXIRKRIDF-IBGZPJMESA-N 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229960002317 succinimide Drugs 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- MLIWQXBKMZNZNF-KUHOPJCQSA-N (2e)-2,6-bis[(4-azidophenyl)methylidene]-4-methylcyclohexan-1-one Chemical compound O=C1\C(=C\C=2C=CC(=CC=2)N=[N+]=[N-])CC(C)CC1=CC1=CC=C(N=[N+]=[N-])C=C1 MLIWQXBKMZNZNF-KUHOPJCQSA-N 0.000 description 1
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 1
- UUORGSXWPOMXJJ-UHFFFAOYSA-N 1-[azido(ethyl)phosphoryl]ethane Chemical compound CCP(=O)(CC)N=[N+]=[N-] UUORGSXWPOMXJJ-UHFFFAOYSA-N 0.000 description 1
- GVJXGCIPWAVXJP-UHFFFAOYSA-N 2,5-dioxo-1-oxoniopyrrolidine-3-sulfonate Chemical compound ON1C(=O)CC(S(O)(=O)=O)C1=O GVJXGCIPWAVXJP-UHFFFAOYSA-N 0.000 description 1
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- QFYSZYAVKZUZCM-UHFFFAOYSA-N 2-diazonio-1,1,1-trifluorohex-2-en-3-olate Chemical compound CCCC(=O)C(=[N+]=[N-])C(F)(F)F QFYSZYAVKZUZCM-UHFFFAOYSA-N 0.000 description 1
- JBVSBLLOZVDAAZ-UHFFFAOYSA-N 2-diazonio-1-[(2-methylpropan-2-yl)oxy]ethenolate Chemical compound CC(C)(C)OC([O-])=C[N+]#N JBVSBLLOZVDAAZ-UHFFFAOYSA-N 0.000 description 1
- UWBALSPTLHOGFE-UHFFFAOYSA-N 2-diazonio-1-phenoxyethenolate Chemical compound [N-]=[N+]=CC(=O)OC1=CC=CC=C1 UWBALSPTLHOGFE-UHFFFAOYSA-N 0.000 description 1
- ZSTBZBURMWJKSQ-UHFFFAOYSA-N 2-diazonio-1-phenylethenolate Chemical compound N#[N+]C=C([O-])C1=CC=CC=C1 ZSTBZBURMWJKSQ-UHFFFAOYSA-N 0.000 description 1
- RKOOOVKGLHCLTP-UHFFFAOYSA-N 2-methylprop-2-enoic acid;propane-1,2,3-triol Chemical compound CC(=C)C(O)=O.OCC(O)CO RKOOOVKGLHCLTP-UHFFFAOYSA-N 0.000 description 1
- WISJLFUMYHMJGQ-UHFFFAOYSA-N 4-[(3-nitrophenyl)methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CC1=CC=CC([N+]([O-])=O)=C1 WISJLFUMYHMJGQ-UHFFFAOYSA-N 0.000 description 1
- VCTBSHQJICJJFV-UHFFFAOYSA-N 4-azido-1-fluoro-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC(N=[N+]=[N-])=CC=C1F VCTBSHQJICJJFV-UHFFFAOYSA-N 0.000 description 1
- RTUYNYSPUHQITK-UHFFFAOYSA-N 4-methylbenzoyl azide Chemical compound CC1=CC=C(C(=O)N=[N+]=[N-])C=C1 RTUYNYSPUHQITK-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- VPAXJOUATWLOPR-UHFFFAOYSA-N Conferone Chemical compound C1=CC(=O)OC2=CC(OCC3C4(C)CCC(=O)C(C)(C)C4CC=C3C)=CC=C21 VPAXJOUATWLOPR-UHFFFAOYSA-N 0.000 description 1
- UYUXSRADSPPKRZ-UHFFFAOYSA-N D-glucuronic acid gamma-lactone Natural products O=CC(O)C1OC(=O)C(O)C1O UYUXSRADSPPKRZ-UHFFFAOYSA-N 0.000 description 1
- UYUXSRADSPPKRZ-SKNVOMKLSA-N D-glucurono-6,3-lactone Chemical compound O=C[C@H](O)[C@H]1OC(=O)[C@@H](O)[C@H]1O UYUXSRADSPPKRZ-SKNVOMKLSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 229920002302 Nylon 6,6 Polymers 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- PJHUABJTDFXYRQ-UHFFFAOYSA-N benzoyl azide Chemical compound [N-]=[N+]=NC(=O)C1=CC=CC=C1 PJHUABJTDFXYRQ-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- 150000001621 bismuth Chemical class 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- SRSPILBBEHNEHD-UHFFFAOYSA-N boranylformonitrile Chemical compound BC#N SRSPILBBEHNEHD-UHFFFAOYSA-N 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- JRZBPELLUMBLQU-UHFFFAOYSA-N carbonazidic acid Chemical class OC(=O)N=[N+]=[N-] JRZBPELLUMBLQU-UHFFFAOYSA-N 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 229920001727 cellulose butyrate Polymers 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- JECGPMYZUFFYJW-UHFFFAOYSA-N conferone Natural products CC1=CCC2C(C)(C)C(=O)CCC2(C)C1COc3cccc4C=CC(=O)Oc34 JECGPMYZUFFYJW-UHFFFAOYSA-N 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- FYLJKQFMQFOLSZ-UHFFFAOYSA-N cyclohexylperoxycyclohexane Chemical compound C1CCCCC1OOC1CCCCC1 FYLJKQFMQFOLSZ-UHFFFAOYSA-N 0.000 description 1
- VDBXLXRWMYNMHL-UHFFFAOYSA-N decanediamide Chemical compound NC(=O)CCCCCCCCC(N)=O VDBXLXRWMYNMHL-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000012933 diacyl peroxide Substances 0.000 description 1
- 150000008049 diazo compounds Chemical class 0.000 description 1
- ZWJPCOALBPMBIC-UHFFFAOYSA-N diphenylketene Chemical compound C=1C=CC=CC=1C(=C=O)C1=CC=CC=C1 ZWJPCOALBPMBIC-UHFFFAOYSA-N 0.000 description 1
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- UZIWRCBLXLKBID-UHFFFAOYSA-N dodecasodium sulfuric acid tetraborate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].OS(O)(=O)=O UZIWRCBLXLKBID-UHFFFAOYSA-N 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- OAMZXMDZZWGPMH-UHFFFAOYSA-N ethyl acetate;toluene Chemical compound CCOC(C)=O.CC1=CC=CC=C1 OAMZXMDZZWGPMH-UHFFFAOYSA-N 0.000 description 1
- DIPBOVZOVZAKGI-UHFFFAOYSA-N ethyl carbamate;sodium Chemical compound [Na].CCOC(N)=O DIPBOVZOVZAKGI-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 229920001002 functional polymer Polymers 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229950002441 glucurolactone Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 108010037896 heparin-binding hemagglutinin Proteins 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- RXPAJWPEYBDXOG-UHFFFAOYSA-N hydron;methyl 4-methoxypyridine-2-carboxylate;chloride Chemical compound Cl.COC(=O)C1=CC(OC)=CC=N1 RXPAJWPEYBDXOG-UHFFFAOYSA-N 0.000 description 1
- 150000002433 hydrophilic molecules Chemical class 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 150000002561 ketenes Chemical class 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000005497 microtitration Methods 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- CTRLRINCMYICJO-UHFFFAOYSA-N phenyl azide Chemical compound [N-]=[N+]=NC1=CC=CC=C1 CTRLRINCMYICJO-UHFFFAOYSA-N 0.000 description 1
- UFJCUIGMJOFBRX-UHFFFAOYSA-N phenyl n-diazocarbamate Chemical compound [N-]=[N+]=NC(=O)OC1=CC=CC=C1 UFJCUIGMJOFBRX-UHFFFAOYSA-N 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- CPGRMGOILBSUQC-UHFFFAOYSA-N phosphoryl azide Chemical class [N-]=[N+]=NP(=O)(N=[N+]=[N-])N=[N+]=[N-] CPGRMGOILBSUQC-UHFFFAOYSA-N 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 238000012643 polycondensation polymerization Methods 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- GHJOIQFPDMIKHT-UHFFFAOYSA-N propane-1,2,3-triol;prop-2-enoic acid Chemical compound OC(=O)C=C.OCC(O)CO GHJOIQFPDMIKHT-UHFFFAOYSA-N 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000007342 radical addition reaction Methods 0.000 description 1
- 238000006485 reductive methylation reaction Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
- 229910052722 tritium Inorganic materials 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dermatology (AREA)
- Materials Engineering (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- General Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Surgery (AREA)
- Materials For Medical Uses (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Graft Or Block Polymers (AREA)
Abstract
Description
Claims (41)
- 1.前処理していない基体に所望の特性を付与する方法であって; 表面を、所望の物理的特性を有するポリマー分子を含有する組成物と接触せしめ ることを特徴とする方法であり; ポリマー分子の各々が、それに共有結合していて、外部からの刺戟に感応して前 処理していない基体に共有結合するために活性種を発生する能力がある潜在性反 応基の少なくとも一個を持ち; 組成物は該潜在性反応基を基体と共有結合している近接部にすることができるよ うにするためにポリマー分子を方向付けることができ; そしてその後潜在性反応基を活性化させて該ポリマー分子を基体に共有結合させ ることを特徴とする方法。
- 2.ポリマー分子が、最も近い潜在性反応基から測定して少なくとも約10オン グストロームの伸長した長さの末端部分を持つ分子を含有する請求の範囲第1項 に記載の方法。
- 3.ポリマー分子が約400の数平均分子量を持つ請求の範囲第1項に記載の方 法。
- 4.ポリマーがポリエチレングリコールである請求の範囲第1項に記載の方法。
- 5.ポリマーがヒアルロン酸である請求の範囲第1項に記載の方法。
- 6.ポリマーがコラーゲンである請求の範囲第1項に記載の方法。
- 7.ポリマーがキトサンである請求の範囲第1項に記載の方法。
- 8.ポリマーがヘパリンである請求の範囲第1項に記載の方法。
- 9.ポリマーがポリビニルアルコールである請求の範囲第1項に記載の方法。
- 10.ポリマー分子の伸長した長さに対する潜在性反応基の比率が、オングスト ロームで、1/10ないし1/700の範囲内にある請求の範囲第1項に記載の 方法。
- 11.該比率が1/50ないし1/400である請求の範囲第10項に記載の方 法。
- 12.前処理していない基体に所望の特性を付与する方法であって; 前処理してない表面を、所望の特性を有するポリマー分子の溶液を含有する組成 物と接触せしめることを特徴とする方法であり; ポリマー分子の各々が、それに共有結合していて、外部からの刺戟の適用による 潜在性反応基の活性化に感応してポリマー分子を潜在性反応基を介して該表面に 共有結合するために、遊離ラジカル、カルベン、ナイトレンおよび励起状態にあ るケトンから成る群から選ばれた活性種を発生する能力がある潜在性反応基の少 なくとも一個を持ち; 潜在性反応基に対するポリマー分子の伸長した長さの平均比率が、オングストロ ームで、1/10ないし1/700の範囲内にあり; そしてポリマー分子は、最も近い潜在性反応基から測定して少なくとも約10オ ングストロームの伸長した長さの末端部分を持ち; 組成物は潜在性反応基を表面と共有結合する近接部にすることができるように空 間的にポリマー分子を方向付けることができ; そしてその後潜在性反応基を活性化させてポリマー分子を表面に共有結合させる ことを特徴とする方法。
- 13.ポリマー分子が約400の数平均分子量を持つ請求の範囲第12項に記載 の方法。
- 14.親水性が該表面の所望の特性であり、該方法が親水性のポリマーの分子を 使用することを特徴とする請求の範囲第12項に記載の方法。
- 15.ポリマーがポリエチレングリコール、ヒアルロン酸またはポリビニルアル コールである請求の範囲第12項に記載の方法。
- 16.その組成物が適用される表面の表面特性を変性するための潜在反応性ポリ マー塗料組成物であって;組成物が所望の特性を有するポリマーの分子の溶液を 含有し; ポリマー分子が、それに共有結合していて、該表面に共有結合するために、特定 の外部からの刺戟に感応して活性種を発生する能力がある潜在性反応基を持ち; 組成物がポリマー分子の潜在性反応基を表面と共有結合する近接部になるように させることができる方法。
- 17.潜在性反応基がベンゾフェノン、アセトフェノンまたはアリールアジドで ある請求の範囲第16項に記載の塗料組成物。
- 18.ポリマーがポリエチレングリコールである請求の範囲第17項に記載の塗 料組成物。
- 19.ポリマーがヒアルロン酸である請求の範囲第17項に記載の塗料組成物。
- 20.ポリマーがコラーゲンである請求の範囲第17項に記載の塗料組成物。
- 21.ポリマーがキトサンである請求の範囲第17項に記載の塗料組成物。
- 22.ポリマーがヘパリンである請求の範囲第17項に記載の塗料組成物。
- 23.ポリマーがポリビニルアルコールである請求の範囲第17項に記載の塗料 組成物。
- 24.潜在性反応基がポリマーに対して相対的に疎水性である請求の範囲第16 項に記載の塗料組成物。
- 25.ポリマー分子の伸長した長さに対する潜在性反応基の平均比率が、オング ストロームで、1/10ないし1/700の範囲内にある請求の範囲第17項に 記載の塗料組成物。
- 26.ポリマーの特性を仕掛け表面に付与するポリマー性塗膜を備えた表面を持 つ仕掛けであって;蕨塗膜はポリマー分子の多数;そして潜在性反応基に活性種 を発生せしめ該表面に結合せしめるために特定の外部からの刺戟により該反応基 を活性化することから生じる潜在性反応基の残基の多数を含有し:該ポリマー分 子は、仕掛け表面にポリマーの特性を付与するのに十分な量で該潜在性反応基の 残基を介して、該表面に共有結合している仕掛け。
- 27.該潜在性反応基の残基が、遊離ラジカル、カルベン、ナイトレンまたは励 起状態にあるケトンの発生から形成された残基である請求の範囲第26項に記載 の仕掛け。
- 28.ポリマー分子を備えている表面が、被覆してない仕掛け表面と比較して比 較的親水性である請求の範囲第26項に記載の仕掛け。
- 29.ポリマーがポリエチレングリコールである請求の範囲第26項に記載の仕 掛け。
- 30.ポリマーがヒアルロン酸である請求の範囲第26項に記載の仕掛け。
- 31.ポリマーがコラーゲンである請求の範囲第26項に記載の仕掛け。
- 32.ポリマーがキトサンである請求の範囲第26項に記載の仕掛け。
- 33.ポリマーがヘパリンである請求の範囲第26項に記載の仕掛け。
- 34.ポリマーがポリビニルアルコールである請求の範囲第26項に記載の仕掛 け。
- 35.その基体に共有結合しているポリマー鎖の多数を基体に提供する方法であ って; 基体と、その(化学単位の)各々がそれ(化学単位)に共有結合している潜在性 反応基を有する化学単位の多数と接触させ; 該潜在性反応基を外部から刺戟して活性種の発生を介して基体に該潜在性反応基 を共有結合せしめ;そして該単位に、モノマー、オリゴマーまたはポリマーを必 要な重合で共有結合せしめて、該化学単位から伸長しそして基体に該潜在性反応 基の残基を介して共有結合しているポリマー鎖を付与することを特徴とする方法 。
- 36.該基体が前処理してない表面である請求の範囲第35項に記載の方法。
- 37.前処理してない基体に所望の特性を付与する方法であって; 基体を、それ(モノマー分子)に共有結合していて、外部からの刺戟により活性 化して活性種を発生して、前処理してない基体に対するモノマーの共有結合を起 こさせることのできる潜在性反応基を有するモノマー分子を含有する組成物を接 触させ; 該潜在性反応基を活性化して該共有結合を形成せしめ;次に、かくして基体に共 有結合したモノマー分子を、該共有結合したモノマーと重台できるかまたは共重 合できるモノマーまたはオリゴマーの存在下の重合条件に処して、潜在性反応基 を介して基体に共有結合したポリマー分子を形成せしめる方法であって;且つポ リマー分子は所望の特性を有するポリマーのそれであることを特徴する方法。
- 38.架橋したポリマーを製造する方法であって;その(ポリマー分子)の各々 がそれ(ポリマー分子)に共有結合していて、外部からの刺戟の適用により該ポ リマー分子の潜在性反応基のない部分と共有結合することのできる潜在性反応基 を有するポリマー分子の多数を溶液中に供給し; そして該外部からの刺戟を適用してポリマー分子間に該共有結合を起こさせるこ とを特徴とする方法。
- 39.請求の範囲第38項に記載の方法からできるポリマーゲル。
- 40.請求の範囲第38項に記載の方法からできる薄いフィルム。
- 41.前処理してない表面に所望のポリマーの特性を付与する方法であって: 表面を、特定の外部からの刺戟の適用による活性化で表面に共有結合できる潜在 性反応基を有する分子を含有する組成物と接触させ; 潜在性反応基を表面と共有結合する近接部に来させ;その後、かくして方向付け られた潜在性分子にポリマー分子を共有結合させ; その後、該潜在性反応基を活性化してそれらを表面に共有結合せしめる方法であ って;且つ 該ポリマー分子は所望の特性を有するポリマーであることを特徴とする方法。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22314988A | 1988-07-22 | 1988-07-22 | |
| US223,149 | 1988-07-22 | ||
| PCT/US1988/004487 WO1990000887A1 (en) | 1988-07-22 | 1988-12-15 | Preparation of polymeric surfaces |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH03505979A true JPH03505979A (ja) | 1991-12-26 |
| JP2855224B2 JP2855224B2 (ja) | 1999-02-10 |
Family
ID=22835252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1501785A Expired - Lifetime JP2855224B2 (ja) | 1988-07-22 | 1988-12-15 | 高分子表面の調製 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0425485B1 (ja) |
| JP (1) | JP2855224B2 (ja) |
| AT (1) | ATE196728T1 (ja) |
| DE (1) | DE3856430T2 (ja) |
| WO (1) | WO1990000887A1 (ja) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03103264A (ja) * | 1989-05-11 | 1991-04-30 | Kanegafuchi Chem Ind Co Ltd | 生体適合性に優れた表面を有する医療用具の製造方法 |
| JP2003532434A (ja) * | 1997-08-15 | 2003-11-05 | サーモディックス,インコーポレイティド | 生物学的反応成分を有する潜伏反応性ポリマー |
| JP2004536633A (ja) * | 2001-05-21 | 2004-12-09 | ノバルティス アクチエンゲゼルシャフト | 絡み合った親水性ポリマーを有するボトル−ブラシ型コーティング |
| JP2006516660A (ja) * | 2002-12-19 | 2006-07-06 | ジョンソン・アンド・ジョンソン・ビジョン・ケア・インコーポレイテッド | ペプチド含有コーティングを備えた生体医用装置 |
| JP2019063783A (ja) * | 2017-09-29 | 2019-04-25 | 東ソー株式会社 | 表面修飾多孔質膜及びその製造方法 |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1335721C (en) * | 1987-12-24 | 1995-05-30 | Patrick E. Guire | Biomolecule attached to a solid surface by means of a spacer and methods of attaching biomolecules to surfaces |
| US5192316A (en) * | 1988-02-16 | 1993-03-09 | Allergan, Inc. | Ocular device |
| US5143854A (en) * | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5547839A (en) | 1989-06-07 | 1996-08-20 | Affymax Technologies N.V. | Sequencing of surface immobilized polymers utilizing microflourescence detection |
| US6955915B2 (en) | 1989-06-07 | 2005-10-18 | Affymetrix, Inc. | Apparatus comprising polymers |
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US6919211B1 (en) | 1989-06-07 | 2005-07-19 | Affymetrix, Inc. | Polypeptide arrays |
| CA2066660C (en) * | 1989-09-15 | 2002-07-30 | Cary Reich | Method for achieving epithelialization of synthetic lenses |
| GB9113875D0 (en) * | 1991-06-27 | 1991-08-14 | Biointeractions Ltd | Polymer coatings |
| US6090901A (en) * | 1991-07-05 | 2000-07-18 | Biocompatibles Limited | Polymeric surface coatings |
| US5705583A (en) * | 1991-07-05 | 1998-01-06 | Biocompatibles Limited | Polymeric surface coatings |
| US6743878B2 (en) | 1991-07-05 | 2004-06-01 | Biocompatibles Uk Limited | Polymeric surface coatings |
| AU3469893A (en) * | 1992-01-15 | 1993-08-03 | Allergan, Inc. | Hydrogel compositions and structures made from same |
| AU3664693A (en) * | 1992-02-13 | 1993-09-03 | Bio-Metric Systems, Inc. | Immobilization of chemical species in crosslinked matrices |
| US5292514A (en) * | 1992-06-24 | 1994-03-08 | Minnesota Mining And Manufacturing Company | Azlactone-functional substrates, corneal prostheses, and manufacture and use thereof |
| US5824651A (en) * | 1993-05-10 | 1998-10-20 | Universite De Montreal | Process for modification of implant surface with bioactive conjugates for improved integration |
| ES2131684T3 (es) * | 1993-05-10 | 1999-08-01 | Univ Montreal | Modificacion de la superficie de un implante con conjugados bioactivos para mejorar su integracion. |
| US5876454A (en) * | 1993-05-10 | 1999-03-02 | Universite De Montreal | Modified implant with bioactive conjugates on its surface for improved integration |
| DE4444445C2 (de) * | 1994-12-14 | 1998-07-02 | Keller Ruprecht Priv Doz Dr Dr | Verfahren zur Herstellung gewebeverträglicher Substrate, gewebeverträgliches Substrat und seine Verwendung |
| DE19724869C2 (de) * | 1997-06-12 | 1999-05-12 | Henkel Kgaa | Verwendung von Citosanderivaten zur Oberflächenbeschichtung |
| TW396187B (en) | 1997-09-23 | 2000-07-01 | Novartis Ag | Method of hydrogel surface treatment and article formed therefrom |
| WO1999055396A1 (en) | 1998-04-27 | 1999-11-04 | Surmodics, Inc. | Bioactive agent release coating |
| KR100698559B1 (ko) | 1999-06-11 | 2007-03-21 | 넥타르 테라퓨틱스 에이엘, 코포레이션 | 키토산 및 폴리(에틸렌 글리콜) 또는 관련 폴리머로부터유래되는 하이드로겔 |
| MXPA02008847A (es) * | 2000-03-10 | 2003-02-12 | Novartis Ag | Polimeros reactivos. |
| US8101196B2 (en) | 2001-06-26 | 2012-01-24 | Biointeractions, Ltd. | Polysaccharide biomaterials and methods of use thereof |
| US7348055B2 (en) | 2001-12-21 | 2008-03-25 | Surmodics, Inc. | Reagent and method for providing coatings on surfaces |
| US7097850B2 (en) | 2002-06-18 | 2006-08-29 | Surmodics, Inc. | Bioactive agent release coating and controlled humidity method |
| JP5014576B2 (ja) | 2002-09-03 | 2012-08-29 | ワットマン リミテッド | 多孔質複合膜及びその製造法 |
| DE10328815A1 (de) * | 2003-06-21 | 2005-01-05 | Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin | Beschichtungssystem für Implantate zur Erhöhung der Gewebsverträglichkeit |
| US20050220841A1 (en) | 2004-04-06 | 2005-10-06 | Dewitt David M | Coating compositions for bioactive agents |
| EP2052045A4 (en) | 2006-08-18 | 2012-09-12 | Commw Scient Ind Res Org | POLYMERIC COATINGS AND METHODS FOR FORMING SAME |
| US8795782B2 (en) | 2006-08-18 | 2014-08-05 | Commonwealth Scientific And Industrial Research Organisation | Polymeric coatings and methods for forming them |
| GB0616724D0 (en) | 2006-08-23 | 2006-10-04 | Isis Innovation | Surface adhesion using arylcarbene reactive intermediates |
| EP2403825B1 (en) | 2009-03-02 | 2019-09-11 | Oxford Advanced Surfaces Ltd | Chemical agents capable of forming covalent 3-d networks |
| EP2724163B1 (en) | 2011-06-24 | 2017-08-09 | The Regents of The University of California | Microfluidic devices and methods for separating and detecting constituents in a fluid sample |
| EP2900740B1 (en) | 2012-09-28 | 2017-08-23 | Sophion Bioscience A/S | A method for applying a coating to a polymeric substrate |
| GB2517864B (en) | 2013-03-07 | 2015-12-09 | Univ California | Electrophoretic separation devices and methods for using the same |
| WO2017221045A1 (en) | 2016-06-24 | 2017-12-28 | Centre National De La Recherche Scientifique (Cnrs) | Surface-modified polymeric implantable substrates grafted with a properties-imparting compound using clip chemistry |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3955012A (en) * | 1970-08-06 | 1976-05-04 | Zaidan Hojin, Seisan Kaihatsu Kagaku Kenkyusho | Method for manufacturing medical articles composed of silicone rubber coated with collagen |
| US3826678A (en) * | 1972-06-06 | 1974-07-30 | Atomic Energy Commission | Method for preparation of biocompatible and biofunctional materials and product thereof |
| US4373009A (en) * | 1981-05-18 | 1983-02-08 | International Silicone Corporation | Method of forming a hydrophilic coating on a substrate |
| US4722906A (en) * | 1982-09-29 | 1988-02-02 | Bio-Metric Systems, Inc. | Binding reagents and methods |
| JPS6145765A (ja) * | 1984-08-07 | 1986-03-05 | 宇部興産株式会社 | 血管補綴物及びその製造方法 |
| AU615637B2 (en) * | 1986-10-17 | 1991-10-10 | Surmodics, Inc. | Improvement of the biocompatibility of solid surfaces |
-
1988
- 1988-12-15 WO PCT/US1988/004487 patent/WO1990000887A1/en not_active Ceased
- 1988-12-15 AT AT89901480T patent/ATE196728T1/de not_active IP Right Cessation
- 1988-12-15 EP EP89901480A patent/EP0425485B1/en not_active Expired - Lifetime
- 1988-12-15 DE DE3856430T patent/DE3856430T2/de not_active Expired - Lifetime
- 1988-12-15 JP JP1501785A patent/JP2855224B2/ja not_active Expired - Lifetime
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03103264A (ja) * | 1989-05-11 | 1991-04-30 | Kanegafuchi Chem Ind Co Ltd | 生体適合性に優れた表面を有する医療用具の製造方法 |
| JP2003532434A (ja) * | 1997-08-15 | 2003-11-05 | サーモディックス,インコーポレイティド | 生物学的反応成分を有する潜伏反応性ポリマー |
| JP2012063361A (ja) * | 1997-08-15 | 2012-03-29 | Surmodics Inc | 生物学的反応成分を有する潜伏反応性ポリマー |
| JP2004536633A (ja) * | 2001-05-21 | 2004-12-09 | ノバルティス アクチエンゲゼルシャフト | 絡み合った親水性ポリマーを有するボトル−ブラシ型コーティング |
| JP2006516660A (ja) * | 2002-12-19 | 2006-07-06 | ジョンソン・アンド・ジョンソン・ビジョン・ケア・インコーポレイテッド | ペプチド含有コーティングを備えた生体医用装置 |
| JP2019063783A (ja) * | 2017-09-29 | 2019-04-25 | 東ソー株式会社 | 表面修飾多孔質膜及びその製造方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0425485A1 (en) | 1991-05-08 |
| DE3856430T2 (de) | 2001-05-03 |
| JP2855224B2 (ja) | 1999-02-10 |
| ATE196728T1 (de) | 2000-10-15 |
| WO1990000887A1 (en) | 1990-02-08 |
| EP0425485B1 (en) | 2000-10-04 |
| DE3856430D1 (de) | 2000-11-09 |
| EP0425485A4 (en) | 1992-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH03505979A (ja) | 高分子表面の調製 | |
| US5741551A (en) | Preparation of polymeric surfaces | |
| US5002582A (en) | Preparation of polymeric surfaces via covalently attaching polymers | |
| JP3455217B2 (ja) | 架橋マトリックス中の化学種の固定 | |
| US10363340B2 (en) | Poly(oligoethylene glycol methacrylate) hydrogel compositions, and methods of use thereof | |
| JP4948740B2 (ja) | 基材を表面改質する方法、及びそれから得られる改質された基材 | |
| US6835410B2 (en) | Bottle-brush type coatings with entangled hydrophilic polymer | |
| JP6693983B2 (ja) | 固定された生物学的実体 | |
| Fairbanks et al. | Inhibition of protein and cell attachment on materials generated from N-(2-hydroxypropyl) acrylamide | |
| JPH05123394A (ja) | 抗血栓性物質の固定化方法 | |
| EP1364664A1 (de) | Verfahren zum Beschichten eines Stents mit einer Polysaccharid-Lage sowie dazugehörige Stents | |
| EP2106812B1 (en) | Methods of Making and Using Surfactant Polymers | |
| CN113667141A (zh) | 抗蛋白粘附的海藻酸盐水凝胶及其制备方法和应用 | |
| EP1095966A2 (en) | Process for the modification of a material surface | |
| Thierry et al. | Biomimetic hemocompatible coatings through immobilization of hyaluronan derivatives on metal surfaces | |
| EP1086149A1 (en) | Surfactants that mimic the glycocalyx | |
| CN108129687A (zh) | 一种表面为磷酰胆碱的仿细胞外层膜结构涂层的制备方法 | |
| CN108794794B (zh) | 一种改性材料表面生物相容性的方法及其制备的仿生涂层 | |
| JP3056512B2 (ja) | 材料表面の改質方法 | |
| CA1340345C (en) | Preparation of polymeric surfaces | |
| CN108659168A (zh) | 一种双仿生聚合物及其制备方法与应用 | |
| Mutch et al. | Surface modification of polycaprolactone with sulfated alginate for enhanced binding of a heparin-binding protein | |
| YALI | Surface modification of the electroactive polymer, polypyrrole, and its applications as a biomaterial |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071127 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081127 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091127 Year of fee payment: 11 |
|
| EXPY | Cancellation because of completion of term | ||
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091127 Year of fee payment: 11 |